Cecropin A Alleviates Inflammation Through Modulating the Gut Microbiota of C57BL/6 Mice With DSS-Induced IBD
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cecropin A Alleviates Inflammation Through Modulating the Gut Microbiota of C57BL/6 Mice With DSS-Induced IBD
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-10
DOI
10.3389/fmicb.2019.01595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
- (2018) Liam Chung et al. Cell Host & Microbe
- Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes
- (2018) Fenfen Zhou et al. INFLAMMATORY BOWEL DISEASES
- Antibiotics in IBD: Still a Role in the Biological Era?
- (2018) Oren Ledder et al. INFLAMMATORY BOWEL DISEASES
- Cecropin A Modulates Tight Junction-Related Protein Expression and Enhances the Barrier Function of Porcine Intestinal Epithelial Cells by Suppressing the MEK/ERK Pathway
- (2018) Zhenya Zhai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- You are what you eat: diet, health and the gut microbiota
- (2018) Niv Zmora et al. Nature Reviews Gastroenterology & Hepatology
- A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets
- (2018) Jun Hu et al. Cell Host & Microbe
- Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis
- (2017) Marco Constante et al. INFLAMMATORY BOWEL DISEASES
- Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against EnterohemorrhagicEscherichia coliO157:H7 Infection
- (2017) Hongbo Yi et al. JOURNAL OF IMMUNOLOGY
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Intestinal Microbiota-Derived GABA Mediates Interleukin-17 Expression during Enterotoxigenic Escherichia coli Infection
- (2017) Wenkai Ren et al. Frontiers in Immunology
- High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells
- (2016) Akhilesh Rai et al. Acta Biomaterialia
- Effect of Lactobacillus Strains on Intestinal Microflora and Mucosa Immunity in Escherichia coli O157:H7-Induced Diarrhea in Mice
- (2016) Xin Bian et al. CURRENT MICROBIOLOGY
- Resistance to colistin: what is the fate for this antibiotic in pig production?
- (2016) Mohamed Rhouma et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics andin vivoefficacy of optimized oncocin derivatives
- (2016) Rico Schmidt et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances T reg and T H 17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding
- (2016) Rui-Cong Chen et al. TOXICOLOGY LETTERS
- Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets
- (2016) Vipul Yadav et al. Translational Research
- Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
- (2016) Noortje Ijssennagger et al. TRENDS IN MOLECULAR MEDICINE
- Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn’s disease
- (2016) Walid Mottawea et al. Nature Communications
- Dietary Geraniol by Oral or Enema Administration Strongly Reduces Dysbiosis and Systemic Inflammation in Dextran Sulfate Sodium-Treated Mice
- (2016) Luigia De Fazio et al. Frontiers in Pharmacology
- High therapeutic efficacy of Cathelicidin-WA against postweaning diarrhea via inhibiting inflammation and enhancing epithelial barrier in the intestine
- (2016) Hongbo Yi et al. Scientific Reports
- Antimicrobial peptide Cathelicidin-BF prevents intestinal barrier dysfunction in a mouse model of endotoxemia
- (2015) Deguang Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inflammatory bowel disease, liver diseases and endothelial function
- (2015) Marco Matteo Ciccone et al. Journal of Cardiovascular Medicine
- Cathelicidin-BF, a Novel Antimicrobial Peptide from Bungarus fasciatus, Attenuates Disease in a Dextran Sulfate Sodium Model of Colitis
- (2015) Haiwen Zhang et al. MOLECULAR PHARMACEUTICS
- α-Haemolysin ofEscherichia coliin IBD: a potentiator of inflammatory activity in the colon
- (2014) Roland Bücker et al. GUT
- Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K881
- (2014) K. M. Yang et al. JOURNAL OF ANIMAL SCIENCE
- Intestinal microbiota: A source of novel biomarkers in inflammatory bowel diseases?
- (2013) David Berry et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Localized Permeabilization of E. coli Membranes by the Antimicrobial Peptide Cecropin A
- (2013) Nambirajan Rangarajan et al. BIOCHEMISTRY
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon
- (2012) Xiaolei Ze et al. ISME Journal
- Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study
- (2012) M. P. Kronman et al. PEDIATRICS
- Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli
- (2012) Shudan Wu et al. PEPTIDES
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach
- (2011) Qinghua He et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease
- (2010) T. Jess et al. GUT
- Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo
- (2009) E. Miyauchi et al. JOURNAL OF DAIRY SCIENCE
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Role of probiotic therapy in IBD
- (2008) Kim Isaacs et al. INFLAMMATORY BOWEL DISEASES
- Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun
- (2008) Yea Ping Lin et al. INFLAMMATORY BOWEL DISEASES
- Antimicrobial Drug Resistance in Human Nontyphoidal Salmonella Isolates in Europe 2000–2004: A Report from the Enter-net International Surveillance Network
- (2008) Sally Meakins et al. Microbial Drug Resistance
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation